Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2002
04/18/2002WO2001080717A3 Methods and compositions for the diagnosis of schizophrenia
04/18/2002WO2001075448A3 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
04/18/2002WO2001075151A3 Method for detecting macromolecular biopolymers by means of an electrode arrangement
04/18/2002WO2001073433A3 Methods relating to self-interacting oligomeric complexes
04/18/2002WO2001072777A3 Human transcription factors
04/18/2002WO2001069241A3 Apparatus and method for high throughput electrorotation analysis
04/18/2002WO2001068912A3 Diagnosis of diseases associated with tumor suppressor genes and oncogenes
04/18/2002WO2001066803A3 Phytomics: a genomic-based approach to herbal compositions
04/18/2002WO2001064913A3 Cell cycle proteins associated with rad9, compositions and methods of use
04/18/2002WO2001064876A3 Human schizophrenia gene
04/18/2002WO2001064833A3 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor
04/18/2002WO2001063284A3 Internal standards and controls for multiplexed assay
04/18/2002WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof
04/18/2002WO2001060400A3 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
04/18/2002WO2001059457A3 Assay for detection of viral fusion inhibitors
04/18/2002WO2001059159A3 Molecular biological kit apparatus and method
04/18/2002WO2001058916A3 Antibodies to ccr5
04/18/2002WO2001058356A3 Method for determining absolute and effective blood viscosity
04/18/2002WO2001057527A3 Process for the identification of igg-producing cells
04/18/2002WO2001057238A3 Electrochemical test strip for use in analyte determination
04/18/2002WO2001053534A3 Method of identifying the function of a test agent
04/18/2002WO2001052718A8 Diet and activity monitoring device
04/18/2002WO2001051520A3 Nogo receptor-mediated blockade of axonal growth
04/18/2002WO2001050132A3 Determination of changes in the prostate of dogs
04/18/2002WO2001040271A3 Cancer associated antigens and uses therefor
04/18/2002WO2001034789A3 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression
04/18/2002WO2001034202A3 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells
04/18/2002WO2001031060A3 Identical-by-descent fragment enrichment
04/18/2002WO2001027324A3 Converting diploidy to haploidy for genetic diagnosis
04/18/2002WO2001025770A3 Measuring device for detecting the gas content in fluids
04/18/2002WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same
04/18/2002WO2000073417A9 In vitro cell culture device including cartilage and methods of using the same
04/18/2002WO2000071752A9 Assay for the detection of paclitaxel resistant cells in human tumors
04/18/2002WO2000071742A9 An apparatus for the analysis of the electrophysiology of neuronal cells and its use in high-throughput functional genomics
04/18/2002WO2000070341A9 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
04/18/2002WO2000070073A9 Method for sequencing nucleic acid molecules
04/18/2002WO2000068411A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
04/18/2002WO2000067793A9 Death domain containing receptor 4
04/18/2002US20020046412 Use for finding active compounds for crop protection
04/18/2002US20020046002 Method to evaluate the quality of database search results and the performance of database search algorithms
04/18/2002US20020045941 Artificial skin and method for evaluating UV screening agent by use of the same
04/18/2002US20020045737 Enterococcus faecalis polynucleotides and polypeptides
04/18/2002US20020045579 Modulation of inflammation related to columnar epithelia
04/18/2002US20020045577 Human schizophrenia gene
04/18/2002US20020045566 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
04/18/2002US20020045564 Methods of modulating muscle contraction
04/18/2002US20020045278 Immunoassay device and immunoassay method using the same
04/18/2002US20020045277 Qualitative and quantitative monitoring of particles in sample; obtain sample, insert detector, detect bound particle, determine physical properties of bound particles
04/18/2002US20020045276 Analyte assay using particulate labels
04/18/2002US20020045275 Matrix for monitoring preferential particles in sample
04/18/2002US20020045274 Matrix for monitoring preferential particles in sample
04/18/2002US20020045273 Test methods and devices
04/18/2002US20020045272 Device for detecting particles in fluid
04/18/2002US20020045271 Compounds and methods for identifying compounds that interact with microsomal triglyceride transfer protein binding sites on apolipoprotein b and modulate lipid biosynthesis
04/18/2002US20020045269 Mass spectrometry
04/18/2002US20020045267 Protein dyeing and detecting method
04/18/2002US20020045266 Analyzing structure of solid support; generate matrix, expose to spectrum analysis, evaluate physical properties of support
04/18/2002US20020045237 Bacterial two-hybrid system for protein-protein interaction screening, new strains for use therein, and their applications
04/18/2002US20020045235 IKB kinase, subunits thereof, and methods of using same
04/18/2002US20020045217 Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
04/18/2002US20020045202 Enzymatic polypeptide for use in diagnosis, prevention and treatment of inflammatory defects, cancer, diabetes
04/18/2002US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator
04/18/2002US20020045200 Method and apparatus for selective biological material detection
04/18/2002US20020045199 Preventing, inhibiting or enhancing binding between at least one type of pilus subunit and at least one type of periplasmic molecular chaperone in the pilus-forming bacteria for therapy or prophylaxis of diseases
04/18/2002US20020045198 Forms of prostate specific antigens and methods for their detection
04/18/2002US20020045197 Methods of determining protein activity levels using gene expression profiles
04/18/2002US20020045196 Methods of isolating trophoblast cells from maternal blood
04/18/2002US20020045195 Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays
04/18/2002US20020045194 Proteomic analysis
04/18/2002US20020045192 Detection of perferential complex formation in sample; incubate ligand with cell cycle regulatory protein, detect complex formation in sample
04/18/2002US20020045190 Combining a monomer with labeled catalyst particle comprising up-converting phosphor label and a catalyst which identifies catalyst which comprises rare earth ion and phosphor material; polymerization to form polymer bead surrounding particle
04/18/2002US20020045188 Methods for validating polypeptide targets that correlate to cellular phenotypes
04/18/2002US20020045181 Method for displaying result of hybridization experiment using biochip and method for evaluating experimental error of hybridization experiment
04/18/2002US20020045179 Generating chemical profile in cells; obtain mammalian cells, incubate with chemical intermediate, monitor adjustments in gene and protein expression, generate profile
04/18/2002US20020045168 Computer based modeling system
04/18/2002US20020045167 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay
04/18/2002US20020045166 Peptides; for use as tools in gene therapy
04/18/2002US20020045164 Reagents and methods useful for detecting diseases of the lung
04/18/2002US20020045162 Identification of viral agents in breast ducts and antiviral therapy therefore
04/18/2002US20020045161 Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
04/18/2002US20020045159 Ion channel assay methods
04/18/2002US20020045158 Cells for drug discovery
04/18/2002US20020045045 Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
04/18/2002US20020044967 Sustained release preparations
04/18/2002US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines
04/18/2002US20020044938 Compositions and methods for the treatment of inflammatory bowel disease
04/18/2002US20020044935 Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
04/18/2002US20020044932 Monocyte chemoattractant activity of galectin-3
04/18/2002US20020044893 Made using a reversible protecting group to reversibly modify omega-functionalized alkanethiols self-assembled on metal substrates, and immobilizing cells or biomolecules; use in surface plasmon resonance (SPR) imaging
04/18/2002US20020044891 Food quality indicator device
04/18/2002US20020044890 Test member
04/18/2002US20020044285 Coupling elements for surface plasmon resonance sensors
04/18/2002US20020044061 Carbon monoxide and smoke detection apparatus
04/18/2002US20020043651 Fluorescent lifetime assays for non-invasive quantification of analytes such as glucose
04/18/2002US20020043624 Device for delivery of multiple liquid sample streams to a mass spectrometer
04/18/2002US20020043490 Apparatus for the enhancement of water quality in a subterranean pressurized water distribution system
04/18/2002US20020043461 To determine the oxidizable portion of exhaust gases in the presence of the reducible portion with the legally required precision
04/18/2002US20020043459 For sorting cells based on a desired characteristic; reporter-labeled cells can be sorted by presence or level of reporter on cells
04/18/2002US20020043396 Connection method and connection structure of pad electrodes, and inspecting methods for connection state thereof
04/18/2002US20020043111 Method for setting shape and working stress, and working environment of steel member